Breathe Well Live Well
|
Onset Of Asthma Attack Higher Doses Of Inhaled Corticosteroids Has No Effect
allvoices There are two systems in the lungs of persons with asthma. The first one is referred to as is broncho-constriction, which is when the airways narrow during … Asthma exacerbation and large doses of inhaled corticosteroids Inhaled steroids will not help asthma flare ups |
View full post on asthma – Google News
|
Asthma exacerbation and large doses of inhaled corticosteroids
EurekAlert (press release) There is no evidence that increasing the dose of inhaled corticosteroids at the onset of an asthma exacerbation, as part of a patient-initiated action plan, … |
View full post on asthma – Google News
Condition: Asthma
Interventions: Drug: SCH 32088 mometasone furoate (MF) metered-dose inhaler; Drug: Placebo metered-dose inhaler BID
Sponsor: Schering-Plough
Not yet recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
Condition: Asthma
Interventions: Drug: Placebo Inhalation Powder; Drug: Fluticasone Furoate/GW642444 Inhalation Powder; Drug: Fluticasone Furoate/GW642444 Inhalation Powder; Drug: Placebo Oral Capsule; Drug: Prednisolone Oral Capsule
Sponsor: GlaxoSmithKline
Active, not recruiting – verified October 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
Condition: Asthma
Interventions: Drug: BI 671800; Drug: BI 671800; Drug: BI 671800; Drug: Placebo
Sponsor: Boehringer Ingelheim Pharmaceuticals
Recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
Condition: Asthma
Interventions: Drug: BI671800; Drug: Placebo; Drug: Montelukast
Sponsor: Boehringer Ingelheim Pharmaceuticals
Recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
Condition: Asthma
Interventions: Drug: Fluticasone Furoate; Drug: FF/GW642444M; Drug: Placebo
Sponsor: GlaxoSmithKline
Active, not recruiting – verified October 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
Condition: Asthma
Interventions: Drug: FP 100mcg BID plus GSK2190915 100mg QD (AM); Drug: FP 100mcg BID plus GSK2190915 300mg QD (AM); Drug: FP 100mcg BID plus montelukast 10mg QD (PM); Drug: FP 100mcg BID plus placebo BID; Drug: FP/SAL 100/50mcg BID plus placebo BID
Sponsor: GlaxoSmithKline
Recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
Condition: Severe Persistent Asthma
Intervention:
Sponsors: University of Giessen; Activaero GmbH; Hessen Agentur
Recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
Condition: Asthma
Interventions: Drug: Budesonide; Drug: Budesonide; Drug: Budesonide
Sponsor: Activaero GmbH
Recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days